OraSure Technologies Invites You to Join Its 2002 First Quarter Financial Results Conference Call

BETHLEHEM, Pa., Apr 18, 2002 (BW HealthWire) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, will host a conference call with analysts and an audio webcast to discuss the Company's first quarter 2002 financial results beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) on Tuesday, April 30, 2002.

On the call will be Mike Gausling, Chief Executive Officer, Ronald H. Spair, Chief Financial Officer, and R. Sam Niedbala, Chief Science Officer. The call will include brief remarks by management and a question and answer session.

In order to listen to the conference call, please either dial 888/742-2024 (Domestic) or 706/643-0033 (International), or go to OraSure Technologies' Web site, www.orasure.com, and click on the Investor Info link at the top of the page, at least ten minutes prior to the start of the call to register and download and install any necessary audio software.

A replay of the call will be archived on OraSure Technologies' Web site shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until May 3, 2002, by dialing 800/642-1687 (Domestic) or 706/645-9291 (International) and entering the Conference ID #3855928.

The call will be preceded by the release of the Company's financial results, which will occur before the market opens on that day. In addition to the Company's financial performance, the call will cover business developments and certain forward-looking statements.

The webcast will also be distributed over the CCBN (Corporate Communications Broadcast Network) Investor Distribution Network. Institutional investors can access the call via CCBN's password protected event management site, StreetEvents (www.streetevents.com).

    About OraSure Technologies

OraSure Technologies, Inc. is the market leader for oral fluid diagnostics. The Company develops, manufactures, and markets medical devices and diagnostic products for use by insurance companies, public health agencies, clinical laboratories, physicians' offices, and workplace sites. For more information on the Company, please visit www.orasure.com.

CONTACT:          OraSure Technologies, Inc.
                  Ronald H. Spair, 610/882-1820
                  Investorinfo@orasure.com

Copyright (C) 2002 Business Wire.  All rights reserved.